title: Significance of serum leptin and adiponectin levels in Egyptian patients with chronic hepatitis C virus associated hepatic steatosis and fibrosis.
abstract: OBJECTIVE
  To study serum levels of leptin and adiponectin in patients with chronic hepatitis C virus infection genotype-4 (HCV-4) related steatosis and fibrosis.
  
  
  METHODS
  We prospectively studied 45 untreated men with chronic HCV-4, with proven steatosis (group I, 30 patients), and fibrosis (group II, 15 patients), on liver biopsy. In addition, 15 healthy men (group III), matched for age, and body mass index were included. However, we excluded another five patients with steatohepatitis, and six patients with cirrhosis. We measured total serum leptin and adiponectin levels, as potential predictors for liver steatosis and fibrosis. Also, a correlation between these adipokines and various clinical and laboratory data were evaluated. All subjects were selected from Tropical and Internal medicine departments, Menoufiya University Hospital, Menoufiya, Egypt, during the period from February 2010 to August 2011.
  
  
  RESULTS
  In group I, severity of hepatic steatosis was mild, moderate, and severe, in 19 patients (63.5%), 8 patients (26.5%), and 3 patients (10%), respectively. In contrast, in group II, hepatic fibrosis was found to be in stage 1, 2, and 3, in 6 patients (40%), in 6 patients (40%), and in 3 patients (20%), respectively. On comparing group I with group II, there was a significant decrease in serum adiponectin levels (131.4 ± 7.91 pg/mL vs 436 ± 9.75 pg/mL, P < 0.001), while there was no significant difference between both groups regarding serum leptin levels (34.69 ± 7.69 ng/mL vs 35.17 ± 1.06 ng/mL, P > 0.05). However, in the same group, when compared with group III, there was a significant increase in serum leptin levels (34.69 ± 7.69 ng/mL vs 10.69 ± 0.84 ng/mL, P < 0.001), while there was a significant decrease in serum adiponectin levels (131.4 ± 7.91 pg/mL vs 342.4 ± 44.48 pg/mL, P < 0.001). In contrast, in group II, when compared with group III, there was a significant increase in serum leptin and adiponectin levels (35.17 ± 1.06 ng/mL vs 10.69 ± 0.84 ng/mL, P < 0.001, and 436 ± 9.75 pg /mL vs 342.4 ± 44.48 pg/mL, P < 0.05, respectively), while there was no significant difference between both groups regarding serum creatinine (0.83 ± 0.34 vs 0.89 ± 0.24, P > 0.05). On the other hand, serum leptin was not correlated with serum adiponectin in group I and in group II (r = 0.09, P > 0.05, and r = -0.1, P > 0.05, respectively). However, serum adiponectin was significantly negatively correlated with serum aspartate transaminase in group I, but no correlation detected in group II (r =-0.39, P > 0.05, and r = -0.03, P > 0.05).
  
  
  CONCLUSIONS
  In male patients with chronic HCV-4, serum adiponectin levels are elevated in hepatic fibrosis, but decreased in steatosis. Therefore, in contrast to leptin, adiponectin may be used as a non-invasive marker.
authors: Tarek E Korah, Department of Internal Medicine, Faculty of Medicine, Menoufiya University, 32511 Menoufiya, Egypt.
authors: Tarek E
authors: TE
authors: Korah
authors: Sawsan
authors: S
authors: El-Sayed
authors: Maathir K
authors: MK
authors: Elshafie
authors: Ghada E
authors: GE
authors: Hammoda
authors: Manal A
authors: MA
authors: Safan
keywords: Adiponectin; Hepatic fibrosis; Hepatic steatosis; Hepatitis C virus; Leptin
references: J Clin Endocrinol Metab. 2004 Aug;89(8):4010-7
references: 15292342
references: Gut. 2007 Mar;56(3):390-5
references: 17005762
references: J Infect Dis. 2004 Jan 15;189(2):292-302
references: 14722895
references: Am J Gastroenterol. 2006 Nov;101(11):2629-40
references: 16952281
references: J Physiol Pharmacol. 2009 Oct;60 Suppl 3:71-5
references: 19996485
references: Am J Gastroenterol. 1999 Sep;94(9):2467-74
references: 10484010
references: Clin Exp Med. 2011 Jun;11(2):123-9
references: 20714777
references: Scand J Gastroenterol. 2003 Jul;38(7):779-86
references: 12889566
references: Nat Med. 2001 Aug;7(8):947-53
references: 11479628
references: Lancet. 2005 Jul 2-8;366(9479):74-85
references: 15993236
references: J Hepatol. 2000 Jul;33(1):33-7
references: 10905583
references: Clin Endocrinol (Oxf). 2002 Dec;57(6):805-11
references: 12460331
references: J Viral Hepat. 2004 Jan;11(1):91-6
references: 14738564
references: J Clin Endocrinol Metab. 2005 Apr;90(4):2240-3
references: 15644404
references: Am J Gastroenterol. 2003 May;98(5):1135-41
references: 12809839
references: Diabetes Care. 2003 Aug;26(8):2442-50
references: 12882876
references: Clin Chem. 1973 Sep;19(9):984-93
references: 4744825
references: Diagn Microbiol Infect Dis. 2002 Mar;42(3):169-73
references: 11929687
references: J Assoc Physicians India. 2010 Jan;58:30, 35-40
references: 20649096
references: J Clin Pathol. 1960 Mar;13:156-9
references: 13821779
references: Diabet Med. 2008 Aug;25(8):949-55
references: 18959608
references: Clin Lab. 2010;56(3-4):103-10
references: 20476641
references: Clin Chem. 1977 Oct;23(10):1903-11
references: 902417
references: Am J Gastroenterol. 2007 Mar;102(3):634-41
references: 17222326
references: Gastroenterology. 2010 Nov;139(5):1762-73, 1773.e1-5
references: 20637208
references: Int J Med Sci. 2006;3(2):53-6
references: 16614743
references: BMC Gastroenterol. 2007 May 31;7:17
references: 17540037
references: Can J Gastroenterol. 2007 May;21(5):289-94
references: 17505564
references: J Hepatol. 1995 Jun;22(6):696-9
references: 7560864
references: Hepatology. 1999 Jun;29(6):1818-24
references: 10347125
references: J Gen Virol. 1997 Jun;78 ( Pt 6):1341-7
references: 9191927
references: J Hepatol. 2005 Jan;42(1):41-6
references: 15726693
references: J Hepatol. 2004 Dec;41(6):943-9
references: 15582127
references: Hepatology. 2001 Jun;33(6):1358-64
references: 11391523
references: Am J Gastroenterol. 2000 Nov;95(11):3211-7
references: 11095344
references: J Biol Chem. 2003 Oct 10;278(41):40352-63
references: 12878598
references: Exp Clin Endocrinol Diabetes. 2004 Jan;112(1):10-7
references: 14758566
references: J Viral Hepat. 2009 Oct;16(10):689-96
references: 19486470
references: Clin Chem. 1978 Jan;24(1):80-6
references: 618669
references: Eur J Endocrinol. 2005 Jan;152(1):113-8
references: 15762194
references: Arch Med Res. 2009 May;40(4):294-8
references: 19608019
references: Adv Ther. 2007 Sep-Oct;24(5):972-82
references: 18029322
references: Gut. 2006 Nov;55(11):1650-60
references: 17047111
references: J Hepatol. 2006 May;44(5):848-55
references: 16530290
references: Am J Clin Nutr. 2000 Nov;72(5):1074-81
references: 11063431
references: Hepatology. 2002 Apr;35(4):762-71
references: 11915021